EN CN

An innovator in developing therapeutic antibodies and fusion proteins

Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including an IL-10M Fusion Protein Platform(FILTEN), a Bi/Tri-TCE Platform, a Proteolysis Targeting intra-Nanobody (PROTiNb) platform and an antibody discovery platform based on the globally leading mammalian cell display technology. We have also built a differentiated pipeline of leading drug candidates. We have established capabilities that cover the entire drug development process from drug discovery, Chemistry, Manufacturing and Controls (CMC), preclinical research, to early clinical development. We are committed to offering quality innovative drugs to benefit better medicines for all.


Read more

0

+

employees

0

+

R&D platforms on therapeutic antibodies

0

+

patents worldwide

0

+m²

R&D and CMC facilities

Technology

Innovating for more efficient treatment of cancers and autoimmune diseases

We specialize in developing therapeutic antibodies and fusion proteins.
Read more

Pipeline

Pressing forward to combat cancers and autoimmune diseases

We have developed an innovative and differentiated pipeline of biologics, with projects ranging from discovery to clinical stages


Read more

Careers

Moving forward together

Talent development is part of our long-term priority and corporate responsibility.

Read more

+86 769 86088555, Ext. 0

biopharma@fapon.com

3F–4F, Building 10, Dongguan–Taiwan Bio-Tech Collaborative Incubation Center, 1 Taoyuan Road, Dongguan, Guangdong Province, China

Scan and follow Fapon LinkedIn Page

© Guangdong Fapon Biopharma Inc. All rights reserved.

Guangdong ICP No. 2024177910-1